Young Min Park, M.D., Ph.D.

Visiting Scholar
Center for Craniofacial Molecular Biology
Herman Ostrow School of Dentistry of USC

2250 Alcazar St.
CSA 210 – HSC 9062
Los Angeles, CA 90033-9062
Phone: (323) 442-3192
Fax: (323) 442-2981
yp_061@usc.edu

Education
Experience
Publications

Yonsei University, Seoul, Korea
M.S., 2008
Medicine

Yonsei University College of Medicine, Seoul, Korea
Ph.D., 2015
Medicine

  • 2023 – present – Visiting Scholar – University of Southern California, Los Angeles, California
  • 2020 – 2023 – Associate Professor – Yonsei University, Department of Otorhinolaryngology, Seoul, Korea
  • 2018 – 2020 – Clinical Assistant Professor – Yonsei University, Department of Otorhinolaryngology, Seoul, Korea
  • 2017 – 2018 – Clinical Assistant Professor – University Guro Hospital, Department of Otorhinolaryngology (Head & Neck Surgery), Seoul, Korea
  • 2014 – 2017 – Chairman – Bundang Jesaeng Hospital, Deajin Medical Center, Department of Otorhinolaryngology, Seongnam, Korea
  • 2013 – 2014 – Clinical Assistant Professor – Yonsei University, Department of Otorhinolaryngology (Head & Neck Division), Seoul, Korea
  • 2012 – 2013 – Instructor – Yonsei University, Department of Otorhinolaryngology (Head & Neck Division), Seoul, Korea

  1. Park, Y.M., Lin, DC. Moving closer towards a comprehensive view of tumor biology and microarchitecture using spatial transcriptomics. Nat Commun 14, 7017 (2023). https://doi.org/10.1038/s41467-023-42960-6

  2. Park YM, Lee WJ, Lee JG, Lee WS, Choi EC, Chung SM, Kim SH. Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech A. 2009 Jun;19(3):361-8. doi: 10.1089/lap.2008.0320. PMID: 19405798.

  3. Park YM, Lee JG, Lee WS, Choi EC, Chung SM, Kim SH. Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer. Oral Oncol. 2009 Aug;45(8):e62-6. doi: 10.1016/j.oraloncology.2009.02.012. Epub 2009 May 12. PMID: 19442570.

  4. Park YM, Kim WS, Byeon HK, De Virgilio A, Jung JS, Kim SH. Feasiblity of transoral robotic hypopharyngectomy for early-stage hypopharyngeal carcinoma. Oral Oncol. 2010 Aug;46(8):597-602. doi: 10.1016/j.oraloncology.2010.05.003. Epub 2010 Jul 8. PMID: 20619721.

  5. Park YM, Kim WS, De Virgilio A, Lee SY, Seol JH, Kim SH. Transoral robotic surgery for hypopharyngeal squamous cell carcinoma: 3-year oncologic and functional analysis. Oral Oncol. 2012 Jun;48(6):560-6. doi: 10.1016/j.oraloncology.2011.12.011. Epub 2012 Jan 20. PMID: 22265334.

  6. Park YM, Kim WS, Byeon HK, Lee SY, Kim SH. Oncological and functional outcomes of transoral robotic surgery for oropharyngeal cancer. Br J Oral Maxillofac Surg. 2013 Jul;51(5):408-12. doi: 10.1016/j.bjoms.2012.08.015. Epub 2012 Oct 9. PMID: 23063012.

  7. Park YM, Kim WS, Byeon HK, De Virgilio A, Lee SY, Kim SH. Clinical outcomes of transoral robotic surgery for head and neck tumors. Ann Otol Rhinol Laryngol. 2013 Feb;122(2):73-84. doi: 10.1177/000348941312200202. PMID: 23534121.

  8. Park YM, Kim WS, Byeon HK, Lee SY, Kim SH. Surgical techniques and treatment outcomes of transoral robotic supraglottic partial laryngectomy. Laryngoscope. 2013 Mar;123(3):670-7. doi: 10.1002/lary.23767. Epub 2013 Jan 3. PMID: 23288629.

  9. Park YM, Byeon HK, Chung HP, Choi EC, Kim SH. Comparison of treatment outcomes after transoral robotic surgery and supraglottic partial laryngectomy: our experience with seventeen and seventeen patients respectively. Clin Otolaryngol. 2013 Jun;38(3):270-4. doi: 10.1111/coa.12101. PMID: 23441587.

  10. Park YM, Byeon HK, Chung HP, Rho KJ, Kim SH. Robotic resection of benign neck masses via a retroauricular approach. J Laparoendosc Adv Surg Tech A. 2013 Jul;23(7):578-83. doi: 10.1089/lap.2012.0468. Epub 2013 May 25. PMID: 23706127.

  11. Park YM, Byeon HK, Chung HP, Choi EC, Kim SH. Comparison study of transoral robotic surgery and radical open surgery for hypopharyngeal cancer. Acta Otolaryngol. 2013 Jun;133(6):641-8. doi: 10.3109/00016489.2012.761350. Epub 2013 Feb 28. PMID: 23448352.

  12. Park YM, De Virgilio A, Kim WS, Chung HP, Kim SH. Parapharyngeal space surgery via a transoral approach using a robotic surgical system: transoral robotic surgery. J Laparoendosc Adv Surg Tech A. 2013 Mar;23(3):231-6. doi: 10.1089/lap.2012.0197. Epub 2013 Jan 23. PMID: 23343202.

  13. Park YM, Kim WS, Byeon HK, Lee SY, Kim SH. A novel technique for the resection of the symptomatic lingual thyroid: transoral robotic surgery. Thyroid. 2013 Apr;23(4):466-71. doi: 10.1089/thy.2012.0292. Epub 2013 Mar 18. PMID: 23506288.

  14. Park YM, Holsinger FC, Kim WS, Park SC, Lee EJ, Choi EC, Koh YW. Robot-assisted selective neck dissection of levels II to V via a modified facelift or retroauricular approach. Otolaryngol Head Neck Surg. 2013 May;148(5):778-85. doi: 10.1177/0194599813478934. Epub 2013 Feb 21. PMID: 23429040.

  15. Park YM, Lee WJ, Yun IS, Lee DW, Lew DH, Lee JM, Ha JG, Kim WS, Koh YW, Choi EC. Free flap reconstruction after robot-assisted neck dissection via a modified face-lift or retroauricular approach. Ann Surg Oncol. 2013 Mar;20(3):891-8. doi: 10.1245/s10434-012-2731-6. Epub 2012 Nov 6. PMID: 23128940.

  16. The long-term oncological and functional outcomes of transoral robotic surgery in patients with hypopharyngeal cancer. Park YM, Jung CM, Cha D, Kim SH. Oral Oncol. 2017;71:138-143.

  17. A New Clinical Trial of Neoadjuvant Chemotherapy Combined With Transoral Robotic Surgery and Customized Adjuvant Therapy for Patients With T3 or T4 Oropharyngeal Cancer. Park YM, Jung CM, Cha D, Kim DH, Kim HR, Keum KC, Cho NH, Kim SH. Ann Surg Oncol. 2017;24(11):3424-3429.

  18. A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer. Park YM, Keum KC, Kim HR, Cho BC, Kim DH, Cho NH, Kim SH. Ann Surg Oncol. 2018;25(4):864-871.

  19. Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma. Park YM, Kim HR, Cho BC, Keum KC, Cho NH, Kim SH. Oral Oncol. 2017;75:16-21.

  20. Transoral Robotic Surgery With Transoral Retropharyngeal Lymph Node Dissection in Patients With Tonsillar Cancer: Anatomical Points, Surgical Techniques, and Clinical Usefulness. Park YM, Cha D, Koh YW, Choi EC, Kim SH. J Craniofac Surg. 2019;30(1):145-148.

  21. Transoral robotic surgery in patients with stage III/IV hypopharyngeal squamous cell carcinoma: treatment outcome and prognostic factor. Park YM, Kim DH, Kang MS, Lim JY, Koh YW, Kim SH. Acta Otolaryngol. 2019;139(9):816-822.

  22. Gasless transoral robotic thyroidectomy using the DaVinci SP system: Feasibility, safety, and operative technique. Park YM, Kim DH, Moon YM, Lim JY, Choi EC, Kim SH, Holsinger FC, Koh YW. Oral Oncol. 2019;95:136-142.

  23. The First Human Trial of Transoral Robotic Surgery Using a Single-Port Robotic System in the Treatment of Laryngo-Pharyngeal Cancer. Park YM, Kim DH, Kang MS, Lim JY, Choi EC, Koh YW, Kim SH. Ann Surg Oncol. 2019;26:4472-4480.

  24. Real impact of surgical robotic system for precision surgery of parotidectomy: retroauricular parotidectomy using da Vinci surgical system. Park YM, Kim DH, Kang MS, Lim JY, Kim SH, Choi EC, Koh YW. Gland Surg. 2020;9(2):183-191.

  25. Establishing the robotic surgery procedure and techniques for head and neck tumors: a single surgeon’s experience of 945 cases. Park YM, Kim DH, Kang MS, Lim JY, Choi EC, Kim SH, Koh YW. J Robot Surg. 2020;14(6):871-880.

  26. Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy. Park YM, Koh YW. Curr Oncol Rep. 2022;24(2):203-208.

  27. Treatment outcomes of neoadjuvant chemotherapy and transoral robotic surgery in locoregionally advanced laryngopharyngeal carcinoma. Solimeno LS, Park YM, Lim JY, Koh YW, Kim SH. Head Neck. 2021;43(11):3429-3436.

  28. Recent progress of robotic head and neck surgery using a flexible single port robotic system. Park YM, Choi EC, Kim SH, Koh YW. J Robot Surg. J Robot Surg. 2022;16(2):353-360.

    Head and Neck Cancer

  29. A prognostic scoring system using inflammatory response biomarkers in oral cavity squamous cell carcinoma patients who underwent surgery-based treatment. Park YM, Oh KH, Cho JG, Baek SK, Kwon SY, Jung KY, Woo JS. Acta Otolaryngol. 2018;138(4):422-427.

  30. Chronic sinusitis in head and neck cancer patients who received radiotherapy or chemoradiotherapy. Park YM, Cho JG, Woo JS. Eur Arch Otorhinolaryngol. 2018;275(11):2805-2811.

  31. Does p16+ Predict a Favorable Prognosis for Oropharyngeal Cancer? Risk Factors for Treatment Failure for Patients Who Underwent Surgery-Based Therapy. Park YM, Kang MS, Koh YW, Choi EC, Kim SH. Ann Surg Oncol. 2019;26(2):547-554.

  32. Prognostic Significance of Lymph Node Status in p16+ Oropharyngeal Cancer After Surgical Treatment. Park YM, Eo TS, Koh YW, Kim SH, Choi EC. Laryngoscope. 2020;130(8):1973-1979.

    Thyroid

  33. Intraoperative frozen section for the evaluation of extrathyroidal extension in papillary thyroid cancer. Park YM, Wang SG, Goh JY, Shin DH, Kim IJ, Lee BJ. World J Surg. 2015;39:187-93.

  34. Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence. Park YM, Wang SG, Lee JC, Shin DH, Kim IJ, Son SM, Mun M, Lee BJ. Head Neck. 2016 Apr;38 Suppl 1:E1172-6.

  35. Lymph node status of lateral neck compartment in patients with N1b papillary thyroid carcinoma. Park YM, Wang SG, Shin DH, Kim IJ, Son SM, Lee BJ. Acta Otolaryngol. 2016;136(3):319-24.

  36. Predictive factors of right paraesophageal lymph node metastasis in papillary thyroid carcinoma: Single center experience and meta-analysis. Park YM, Lee SM, Kim DW, Shin SC, Lee BJ. PLoS One. 2017 May 17;12(5):e0177956.

  37. Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma. Park YM, Lee DY, Oh KH, Cho JG, Baek SK, Kwon SY, Jung KY, Woo JS. Oral Oncol. 2017;75:1-5.

  38. Changes in Voice- and Swallowing-Related Symptoms After Thyroidectomy: One-Year Follow-Up Study. Park YM, Oh KH, Cho JG, Baek SK, Kwon SY, Jung KY, Woo JS. Ann Otol Rhinol Laryngol. 2018;127(3):171-177.

  39. Comparison of functional outcomes after total thyroidectomy and completion thyroidectomy: Hypoparathyroidism and postoperative complications. Park YM, Kim JR, Oh KH, Cho JG, Baek SK, Kwon SY, Jung KY, Woo JS. Auris Nasus Larynx. 2019;46(1):101-105.

    Laryngology

  40. Phonatory outcome of 585 nm/pulsed-dye laser in the management of glottic leukoplakia. Park YM, Jo KH, Hong HJ, Choi HS. Auris Nasus Larynx. 2014;41:459-63.

  41. New technique for preparing cartilage for intracordal injection: the freezing and grinding method. Park YM, Lee WY, Lim YS, Lee JC, Lee BJ, Wang SG. J Voice. 2014;28:508-11.

  42. A new videokymography system for evaluation of the vibration pattern of entire vocal folds. Wang SG, Park HJ, Lee BJ, Lee SM, Ko B, Lee SM, Park YM. Auris Nasus Larynx. 2016 Jun;43(3):315-21.

  43. Treatment Outcomes of Angiolytic Laser-Assisted Glottoplasty in Patients With Sulcus Vocalis. Park YM, Lim JY, Kang MS, Choi HS. Ann Otol Rhinol Laryngol. 2019;128(5):377-383.

    Salivary Gland

  44. Diagnosis and surgical outcomes of intraparotid facial nerve schwannoma showing normal facial nerve function. Lee DW, Byeon HK, Chung HP, Choi EC, Kim SH, Park YM. Int J Oral Maxillofac Surg. 2013;42:874-9.

  45. Prognostic significance of lymphovascular invasion in patients with salivary duct cell carcinoma of the head and neck. Park YM, AlHashim MA, Yoon SO, Koh YW, Kim SH, Lim JY, Choi EC. Int J Oral Maxillofac Surg. Int J Oral Maxillofac Surg. 2020;49(6):693-699.

  46. Clinical-pathological prognostic factors and treatment failure patterns in T1-2 high-grade parotid gland cancer. Park YM, Yoon SO, Koh YW, Kim SH, Lim JY, Choi EC. Oral Oncol. 2020;110:104884.

  47. Surgical extent and role of adjuvant radiotherapy of surgically resectable, low-grade parotid cancer. Park YM, Kang MS, Kim DH, Koh YW, Kim SH, Lim JY, Choi EC. Oral Oncol. 2020;107:104780.

  48. Comprehensive Analysis of Clinicopathologic Factors Predictive of an Unfavorable Prognosis in Patients With Acinic Cell Carcinoma of the Parotid Gland. Park YM, Yoon SO, Kim JH, Kang MS, Kim DH, Koh YW, Kim SH, Lim JY, Choi EC. Clin Exp Otorhinolaryngol. 2021;14(1):108-115.

  49. Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy. Park YM, Koh YW. Curr Oncol Rep. 2022;24(2):203-208.

    Translational Research

  50. Role of cancer stem cell in radioresistant head and neck cancer. Park YM, Lee SY, Park SW, Kim SH. Auris Nasus Larynx. 2016 Oct;43(5):556-61.

  51. Endoscopic sentinel lymph node biopsy using indocyanine green-neomannosyl human serum albumin. Park YM, Quan YH, Kwon KH, Cho JG, Woo JS, Kim BM, Lee YS, Jeong JM, Kim HK, Song JJ. Laryngoscope. 2018;128(4):E135-E140.

  52. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death. Park YM, Go YY, Shin SH, Cho JG, Woo JS, Song JJ. PLoS One. 2018;13(9):e0203069.

  53. Machine learning-based prediction model using clinico-pathologic factors for papillary thyroid carcinoma recurrence. Park YM, Lee BJ. Sci Rep. 2021;11(1):4948.

  54. Machine learning and magnetic resonance imaging radiomics for predicting human papilloma virus status and prognostic factors in oropharyngeal squamous cell carcinoma. Park YM, Lim JY, Koh YW, Kim SH, Choi EC. Head Neck. 2022;44(4):897-903.

  55. Prediction of treatment outcome using MRI radiomics and machine learning in oropharyngeal cancer patients after surgical treatment. Min Park Y, Yol Lim J, Woo Koh Y, Kim SH, Chang Choi E. Oral Oncol. 2021;122:105559.